ABBV vs LLY
ABBV and LLY side by side — valuation & fundamentals (public data).
Key statistics
| Metric | ABBVAbbVie Inc. | LLYELI LILLY AND COMPANY |
|---|---|---|
| Market cap | $451.60B | $1.11T |
| P/E (TTM) | 72.2 | 39.4 |
| P/B | — | 32.62 |
| P/S | 7.4x | 17.0x |
| Dividend yield | 2.58% | 0.49% |
| Revenue | $61.16B(TTM) | $79.67B(TTM) |
| Revenue growth (YoY) | 8.6% | 44.7% |
| Net income | $6.31B(TTM) | $26.71B(TTM) |
| Earnings growth (YoY) | -1.2% | 94.9% |
| EPS, diluted | $3.54(TTM) | $29.79(TTM) |
| EBIT margin | 24.6% | 40.2% |
| ROE | — | 60.9% |
| ROIC | 18.6% | 26.3% |
| 1y total return | +26.1% | +61.1% |
Figures from SEC filings · for reference only · not investment advice
Growth of $10,000: ABBV vs LLY
| Metric | ABBV | LLY |
|---|---|---|
| End value | $64.0K | $181.9K |
| Total return | +540.0% | +1718.8% |
| CAGR | +19.7% | +32.4% |
| Volatility | 25.9% | 30.1% |
| Sharpe | 0.68 | 0.95 |
| Sortino | 0.94 | 1.48 |
| Max drawdown | -45.1% | -34.5% |
Based on 2600 common trading days, 2016-04-27 → 2026-08-28 · risk-free 3.9% (current short-Treasury, held constant)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)